Developer docs
API playgroundTry for free, no card

Search company profiles

Bellco

Full company profile

uuid000c4og

Namestring
Bellco
Websiteurl
bellco.net
Company typeenum
Private
Founded yearint
1972
Descriptiontext

Bellco is an Italian medical-device company founded in 1972 and headquartered in Mirandola — the heart of one of Europe's most concentrated biomedical manufacturing clusters. The company is positioned as one of the pioneers and protagonists of haemodialysis and, more specifically, continuous renal replacement therapy (CRRT) for critically ill patients with acute kidney injury. Its products and underlying technology centre on renal replacement platforms and the consumables and biofluid-management systems that support them, including the biofluid capabilities added through its 2013 acquisition of Hbiofluids. The addressable market is the global CRRT segment, forecast to reach $2.77B by 2030 at a 9.6% CAGR, where Bellco competes alongside materially larger incumbents including Medtronic, Fresenius Medical Care, and Asahi Kasei.

The business model is a classic B2B specialty medtech model: Bellco sells capital equipment, consumables, and related services to hospitals and critical-care departments, generating a mix of upfront equipment revenue and recurring consumables and service revenue. The company employs 501–1,000 people and operates with a full international C-suite — including a CFO, CTO, CSO, CCO, CMO, and a dedicated Chief Quality Assurance & Regulatory Affairs Officer — consistent with a regulated medical-device exporter. It has raised capital from Charme Capital Partners (2009) and Amadeus Capital Partners (2013), and remains a privately held company. Public commercial information is thin: the company's bellco.net domain currently resolves to an inactive IONOS parking page, and pricing, product catalog, geographic footprint, and revenue are not disclosed in available sources.

Short descriptiontext

Bellco is an Italian medical-device company founded in 1972 that manufactures haemodialysis and continuous renal replacement therapy (CRRT) systems and consumables for hospitals and critical-care units, competing in the global CRRT market alongside Fresenius, Medtronic, and Asahi Kasei.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersMirandola, Italy
HQ citystring
Mirandola
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
haemodialysis equipment, renal replacement therapy, medical devices manufacturing, continuous renal therapy, critical care nephrology
Industry2 codes
1Continuous Renal Replacement Therapy (CRRT) & Acute Dialysis Systems
CodeHLAHAKAFPrimaryYes
2Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges)
CodeHLAHAKAHPrimaryNo
NAICS code1 code
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code1 code
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Renal Care Medical Devices
Social media profiles1 record
Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bellco develops, manufactures, and supplies haemodialysis equipment and continuous renal replacement therapy (CRRT) systems used in hospitals and critical care settings to treat patients with acute kidney injury and chronic renal conditions. The company has European identity and is recognized as a key player in the CRRT market.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product information available. The bellco.net domain is registered via IONOS but not yet connected to a functioning website. The source data does not contain any information about Bellco's products, services, or offerings.

Product and service2 records
1Haemodialysis Equipment
CategoryRenal Care Medical Devices
2Continuous Renal Replacement Therapy (CRRT) Equipment
CategoryCritical Care Medical Devices
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Manufacturer of dialyzers and haemodialysis membranes. Directly comparable to Bellco's renal consumables and replacement therapy product lines.

TypeDirect peer
Description

The global leader in dialysis products and services, providing hemodialysis machines, dialyzers, and CRRT systems. Named alongside Bellco as a key player in the CRRT market and directly comparable in haemodialysis equipment.

TypeDirect peer
Description

Major manufacturer of dialysis and continuous renal replacement therapy systems (e.g., Prismax/PrisMax), directly overlapping with Bellco's CRRT and haemodialysis product portfolio.

TypeDirect peer
Description

Manufactures haemodialysis equipment, dialyzers, and acute dialysis/CRRT systems (Dialog+, Omni). Directly comparable to Bellco in renal devices and consumables for hospitals and clinics.

TypeDirect peer
Description

Producer of dialysis membranes, filters, and CRRT systems (e.g., Hemofeel). Named alongside Bellco as a key CRRT market player with overlapping renal replacement therapy offerings.

TypeDirect peer
Description

Global manufacturer of dialyzers, haemodialysis machines, and related consumables. Directly comparable to Bellco in renal/dialysis device manufacturing for hospital and clinical customers.

TypeDirect peer
Description

Producer of haemodialysis equipment, CRRT systems, and blood purification devices. Competes with Bellco in the same hospital-based renal replacement therapy segment.

TypeBroad incumbent
Description

Named alongside Bellco as a key CRRT market player. Although a broad incumbent across multiple medtech categories, Medtronic's renal therapies overlap with Bellco's CRRT offering.

TypeEmerging player
Description

Developer of compact haemodialysis systems (SC+) for hospital and home use. Comparable to Bellco in haemodialysis device innovation, though focused on a more portable/self-care segment.

TypeEmerging player
Description

Maker of the Tablo haemodialysis system for acute and home settings. An emerging player overlapping with Bellco's acute/hospital and broader haemodialysis markets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bellco

Renal Care Medical Devicesbellco.net

Bellco is an Italian medical-device company founded in 1972 that manufactures haemodialysis and continuous renal replacement therapy (CRRT) systems and consumables for hospitals and critical-care units, competing in the global CRRT market alongside Fresenius, Medtronic, and Asahi Kasei.

What Bellco does

Bellco is an Italian medical-device company founded in 1972 and headquartered in Mirandola — the heart of one of Europe's most concentrated biomedical manufacturing clusters. The company is positioned as one of the pioneers and protagonists of haemodialysis and, more specifically, continuous renal replacement therapy (CRRT) for critically ill patients with acute kidney injury. Its products and underlying technology centre on renal replacement platforms and the consumables and biofluid-management systems that support them, including the biofluid capabilities added through its 2013 acquisition of Hbiofluids. The addressable market is the global CRRT segment, forecast to reach $2.77B by 2030 at a 9.6% CAGR, where Bellco competes alongside materially larger incumbents including Medtronic, Fresenius Medical Care, and Asahi Kasei.

The business model is a classic B2B specialty medtech model: Bellco sells capital equipment, consumables, and related services to hospitals and critical-care departments, generating a mix of upfront equipment revenue and recurring consumables and service revenue. The company employs 501–1,000 people and operates with a full international C-suite — including a CFO, CTO, CSO, CCO, CMO, and a dedicated Chief Quality Assurance & Regulatory Affairs Officer — consistent with a regulated medical-device exporter. It has raised capital from Charme Capital Partners (2009) and Amadeus Capital Partners (2013), and remains a privately held company. Public commercial information is thin: the company's bellco.net domain currently resolves to an inactive IONOS parking page, and pricing, product catalog, geographic footprint, and revenue are not disclosed in available sources.

Bellco firmographics

Firmographics
Name
Bellco
Website
https://bellco.net
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Bellco is an Italian medical-device company founded in 1972 that manufactures haemodialysis and continuous renal replacement therapy (CRRT) systems and consumables for hospitals and critical-care units, competing in the global CRRT market alongside Fresenius, Medtronic, and Asahi Kasei.
Ownership category
akta.pro rank

Bellco industry classification

Industry
Product category
Renal Care Medical Devices
NAICS
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Continuous Renal Replacement Therapy (CRRT) & Acute Dialysis Systems (HLAHAKAF)
akta.pro secondary industry
Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH)

Keywords

  • Haemodialysis equipment
  • Renal replacement therapy
  • Medical devices manufacturing
  • Continuous renal therapy
  • Critical care nephrology

Where Bellco is headquartered

Location

Headquarters

HQ city
Mirandola
HQ country
Italy
HQ region
Europe

Markets served

Bellco business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Bellco product offering

Product offering

Core offering

Bellco develops, manufactures, and supplies haemodialysis equipment and continuous renal replacement therapy (CRRT) systems used in hospitals and critical care settings to treat patients with acute kidney injury and chronic renal conditions. The company has European identity and is recognized as a key player in the CRRT market.

Product overview

No product information available. The bellco.net domain is registered via IONOS but not yet connected to a functioning website. The source data does not contain any information about Bellco's products, services, or offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Haemodialysis Equipment
  • Continuous Renal Replacement Therapy (CRRT) Equipment

Companies that use Bellco

Customer profile

Segments1 record

Ideal customer profiles1 record

Bellco technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bellco partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Bellco competitors and assessment

Company assessment

Direct peers

  • Toray Medical: Manufacturer of dialyzers and haemodialysis membranes. Directly comparable to Bellco's renal consumables and replacement therapy product lines.
  • Fresenius Medical Care: The global leader in dialysis products and services, providing hemodialysis machines, dialyzers, and CRRT systems. Named alongside Bellco as a key player in the CRRT market and directly comparable in haemodialysis equipment.
  • Baxter International: Major manufacturer of dialysis and continuous renal replacement therapy systems (e.g., Prismax/PrisMax), directly overlapping with Bellco's CRRT and haemodialysis product portfolio.
  • B. Braun: Manufactures haemodialysis equipment, dialyzers, and acute dialysis/CRRT systems (Dialog+, Omni). Directly comparable to Bellco in renal devices and consumables for hospitals and clinics.
  • Asahi Kasei Medical: Producer of dialysis membranes, filters, and CRRT systems (e.g., Hemofeel). Named alongside Bellco as a key CRRT market player with overlapping renal replacement therapy offerings.
  • Nipro Corporation: Global manufacturer of dialyzers, haemodialysis machines, and related consumables. Directly comparable to Bellco in renal/dialysis device manufacturing for hospital and clinical customers.
  • Nikkiso: Producer of haemodialysis equipment, CRRT systems, and blood purification devices. Competes with Bellco in the same hospital-based renal replacement therapy segment.

Broad incumbents

  • Medtronic: Named alongside Bellco as a key CRRT market player. Although a broad incumbent across multiple medtech categories, Medtronic's renal therapies overlap with Bellco's CRRT offering.

Emerging players

  • Quanta Dialysis Technologies: Developer of compact haemodialysis systems (SC+) for hospital and home use. Comparable to Bellco in haemodialysis device innovation, though focused on a more portable/self-care segment.
  • Outset Medical: Maker of the Tablo haemodialysis system for acute and home settings. An emerging player overlapping with Bellco's acute/hospital and broader haemodialysis markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Bellco social profiles

Digital presence

Bellco financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bellco leadership team

Management profile

Number of profiles

Profiles8 records

Bellco funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bellco M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bellco

What does Bellco do?

Bellco develops, manufactures, and supplies haemodialysis equipment and continuous renal replacement therapy (CRRT) systems used in hospitals and critical care settings to treat patients with acute kidney injury and chronic renal conditions. The company has European identity and is recognized as a key player in the CRRT market.

When was Bellco founded?

Bellco was founded in 1972. It employs 501 to 1,000 people.

Where is Bellco based?

Bellco is headquartered in Mirandola, Italy, in the Europe region.

Who are Bellco's main competitors?

Direct peers on record are Toray Medical, Fresenius Medical Care, Baxter International, B. Braun, Asahi Kasei Medical, Nipro Corporation and Nikkiso. Medtronic is listed as a broad incumbent. Emerging players are Quanta Dialysis Technologies and Outset Medical.

Does Bellco have an API?

No public API is recorded for Bellco.

What industry is Bellco in?

Bellco's product category is Renal Care Medical Devices. Its primary akta.pro industry code is HLAHAKAF, Continuous Renal Replacement Therapy (CRRT) & Acute Dialysis Systems, with a secondary code of HLAHAKAH, Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges). Its NAICS code is 423450 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals